American Gene Technologies

OverviewSuggest Edit

American Gene Technologies (AGT) is a gene and cell therapeutics company with a proprietary lentiviral platform capable of a variety of applications including large and orphan indications, infectious disease, immune-oncology, and monogenic disorders. It develops an immuno-oncology approach of stimulating gamma-delta (γδ) T cells to attack multiple cancers.
TypePrivate
Founded2007
HQRockville, MD, US
Websiteamericangene.com

Latest Updates

Employees (est.) (Jan 2022)39(-4%)
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at American Gene Technologies

David Pauza

David Pauza

Chief Science Officer
Jeff Galvin

Jeff Galvin

CEO and Founder, Director
Show more

American Gene Technologies Office Locations

American Gene Technologies has an office in Rockville
Rockville, MD, US (HQ)
9640 Medical Center Dr
Rockville, MD, US
9713 Key W Ave
Show all (2)

American Gene Technologies Financials and Metrics

Summary Metrics

Founding Date

2007

American Gene Technologies total Funding

$1.6 m

American Gene Technologies latest funding size

$340 k

Time since last funding

7 years ago
American Gene Technologies's latest funding round in October 2014 was reported to be $340 k. In total, American Gene Technologies has raised $1.6 m
Show all financial metrics

American Gene Technologies Online and Social Media Presence

Embed Graph

American Gene Technologies News and Updates

American Gene Technologies Appoints Dr. Marcus A. Conant as Special Advisor to the CEO

Dr. Conant, one of the first HIV/AIDS treatment pioneers, strengthens AGT’s capacity to progress toward a functional cure Dr. Conant, one of the first HIV/AIDS treatment pioneers, strengthens AGT’s capacity to progress toward a functional cure

American Gene Technologies Announces First Trial Participant Enrolled in Phase 1 Study of AGT103-T Against HIV

ROCKVILLE, Md., Nov. 10, 2020 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT) announced today that the first trial participant was enrolled in the Phase 1 trial of AGT103-T, a new cell and gene therapy for HIV disease. The first trial participant underwent leukapheresis, a procedure for obtai…

American Gene Technologies Frequently Asked Questions

  • When was American Gene Technologies founded?

    American Gene Technologies was founded in 2007.

  • Who are American Gene Technologies key executives?

    American Gene Technologies's key executives are David Pauza and Jeff Galvin.

  • How many employees does American Gene Technologies have?

    American Gene Technologies has 39 employees.

  • Who are American Gene Technologies competitors?

    Competitors of American Gene Technologies include Lupagen, VLVbio and Femtogenix.

  • Where is American Gene Technologies headquarters?

    American Gene Technologies headquarters is located at 9640 Medical Center Dr, Rockville.

  • Where are American Gene Technologies offices?

    American Gene Technologies has an office in Rockville.

  • How many offices does American Gene Technologies have?

    American Gene Technologies has 2 offices.